Has Marc Sakwa, MD received payments from drug or device companies?

Yes. Drug and device makers reported $72,329 in general payments to Marc Sakwa, MD across 242 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marc Sakwa, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marc Sakwa, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marc Sakwa, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Long Beach, CANPI 1750363552

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Abbott at 53.4% of the total. Reporting peaked in 2019 at $39,572 and has fallen 95.1% since, to $1,929 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,329in general payments, 2019–2025

Across 242 payments — averaging $298.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$39K
Medtronic$16K
LSI Solutions Inc$14K
Atricure, Inc.$1K
Abiomed$839
Edwards Lifesciences$726
plus $2K from 10 others

What the payments were for

Consulting fees$30,54042%
Speaking & faculty fees$13,74819%
Travel & lodging$12,37317%
Food & beverage$15,66822%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	88	$38,626
Medtronic(2 entities)	80	$15,561
LSI Solutions Inc	4	$13,746
Atricure, Inc.	19	$1,016
Abiomed	12	$839
Edwards Lifesciences	9	$726
Zimmer Biomet	9	$690
Artivion, Inc.	4	$467
Baxter Healthcare	3	$231
Smith+Nephew	4	$186
AbbVie	4	$75
Bolton Medical Inc	2	$42
Impulse Dynamics (USA) Inc.	1	$36
Johnson & Johnson	1	$33
La Jolla Pharmaceutical Company	1	$31
Terumo Cardiovascular Systems Corporation	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Trifecta GT Tissue Heart Valve$16,327
RAM$13,526
COR KNOT$13,266
CoreValve Evolut$8,342
Epic$7,708
AMPLATZER Occluders$5,600
MitraClip System$4,530
Avalus$3,547
Epic Stented Tissue Valve$1,804
INSPIRIS RESILIA aortic valve$460
Impella$422
Mosaic$419
COREVALVE EVOLUT R$389
AMDS-Ascyrus Medical$363
ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$363
Trifecta Tissue Heart Valve$360
Hancock$255
STERNALOCK BLU SYSTEM$244
Endurant$237
PORTICO$224

How this compares

$72,329 in reported general payments places this provider in the 90th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024

$80,709

Medicare patients

Services billed

127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Long Beach

Ali KhoynezhadLong Beach$476K
Thomas FogartyPortola Valley$3.7M
Steven GundryPalm Springs$1.6M
Armin KiankhooySaint Helena$941K
Ara KlijianMurrieta$916K
Gregory FontanaThousand Oaks$875K
Gansevoort DunningtonSaint Helena$764K
Wilson TsaiWalnut Creek$680K
Fernando FleischmanLos Angeles$608K
Harmik SoukiasianLos Angeles$577K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →